FDA 483 - Interquim S.A. - September 27, 2019

Interquim S.A., an API manufacturer, was cited for significant quality control deficiencies during an FDA inspection. The firm failed to thoroughly investigate unexplained discrepancies in intermediate and finished-API testing and did not obtain quality unit approval for deviations from approved protocols during method validation. These issues highlight a lack of robust quality management system practices.